Glycotope Gmbh Is A Biotechnology Company Located In Berlingermanyit Specializes In Developing Tumor Specific Monoclonal Antibodies Using Its Proprietary Technology Platformthis Platform Targets Tumor Associated Carbohydrate Structures And Glyco Epitopesenabling The Creation Of Innovative Antibody Based Therapeutics For Immuno Oncology The Company Is Focused On Developing A Range Of Therapeutic Antibodiesincluding Naked Antibodiesbispecificsantibody Drug Conjugatesand Fusion Proteinsglycotope Has Identified Over 200 Glycotargets And Is Advancing Several Preclinical And Clinical Programssuch As Gt 005 For Neoplasms And A Phase 3 Compound For Infertilityglycotope Also Operates An Antibody Production Facility In Heidelberggermanywhich Is Near Key Life Science Centerswith A Strong Emphasis On Research And Developmentover 80Of Its Team Is Dedicated To These Activitiescontributing To The Advancement Of Its Therapeutic Compounds
